Dianthus Therapeutics, Inc. (DNTH) Reports Q3 Loss, Tops Revenue Estimates

Dianthus Therapeutics, Inc. (DNTH) came out with a quarterly loss of $0.74 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares to loss of $3.78 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -25.42%. A quarter ago, it was expected that this company would post a loss of $0.50 per share when it actually produced a loss of $0.51, delivering a surprise of -2%.Over the last four quarters, the company ha ...